The result of the FDA meeting was reported by Dr Fowler in a memo. He noted that the possibility of banning all products made before the implementation of the March 1983 regulations was rejected.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates
Key Person(s)
Dr L K Fowler